| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/03/2023 | 10.85% | UBS | $52 → $24 | Downgrades | Buy → Neutral |
| 10/13/2023 | 1.62% | Canaccord Genuity | $55 → $22 | Downgrades | Buy → Hold |
| 08/01/2023 | 149.42% | Barclays | $47 → $54 | Maintains | Overweight |
| 07/28/2023 | 154.04% | Canaccord Genuity | $47 → $55 | Maintains | Buy |
| 07/28/2023 | 181.76% | Baird | $53 → $61 | Maintains | Outperform |
| 05/04/2023 | 117.09% | Barclays | $45 → $47 | Maintains | Overweight |
| 03/29/2023 | 84.76% | UBS | → $40 | Initiates Coverage On | → Buy |
| 02/17/2023 | — | Needham | Downgrades | Buy → Hold | |
| 02/15/2023 | 107.85% | Barclays | $44 → $45 | Maintains | Overweight |
| 02/15/2023 | 177.14% | Needham | → $60 | Reiterates | → Buy |
| 12/21/2022 | 103.23% | Barclays | → $44 | Initiates Coverage On | → Overweight |
| 10/12/2022 | 84.76% | Jefferies | → $40 | Initiates Coverage On | → Buy |
| 07/29/2022 | 177.14% | Needham | $58 → $60 | Maintains | Buy |
| 06/30/2022 | 84.76% | Canaccord Genuity | $50 → $40 | Maintains | Buy |
| 05/03/2022 | 167.9% | Needham | $82 → $58 | Maintains | Buy |
| 02/11/2022 | 278.75% | Needham | $103 → $82 | Maintains | Buy |
| 10/27/2021 | 361.89% | Canaccord Genuity | $80 → $100 | Maintains | Buy |
| 10/13/2021 | 269.52% | Canaccord Genuity | $60 → $80 | Maintains | Buy |
| 10/13/2021 | 292.61% | Barclays | $120 → $85 | Maintains | Overweight |
| 10/12/2021 | 375.75% | Needham | $206 → $103 | Maintains | Buy |
| 09/27/2021 | 851.5% | Needham | $129 → $206 | Maintains | Buy |
| 07/29/2021 | 454.27% | Canaccord Genuity | $95 → $120 | Maintains | Buy |
| 07/29/2021 | 495.84% | Needham | $119 → $129 | Maintains | Buy |
| 07/13/2021 | 454.27% | Barclays | $92 → $120 | Maintains | Overweight |
| 07/12/2021 | 449.65% | Needham | $94 → $119 | Maintains | Buy |
| 05/25/2021 | 324.94% | Barclays | → $92 | Initiates Coverage On | → Overweight |
| 05/18/2021 | 334.18% | Needham | → $94 | Initiates Coverage On | → Buy |
| 05/06/2021 | 380.37% | Baird | $84 → $104 | Maintains | Outperform |
| 05/06/2021 | 338.8% | Canaccord Genuity | $80 → $95 | Maintains | Buy |
| 02/11/2021 | 287.99% | UBS | $64 → $84 | Maintains | Buy |
| 10/21/2020 | 135.57% | Canaccord Genuity | $42 → $51 | Maintains | Buy |
| 10/14/2020 | 117.09% | UBS | $43 → $47 | Maintains | Buy |
| 08/17/2020 | 75.52% | Barclays | $36 → $38 | Maintains | Overweight |
| 05/07/2020 | 84.76% | Canaccord Genuity | $50 → $40 | Maintains | Buy |
| 05/07/2020 | 94% | UBS | $46 → $42 | Maintains | Buy |
| 03/26/2020 | 66.28% | Barclays | $48 → $36 | Maintains | Overweight |
| 11/06/2019 | 107.85% | Baird | $27 → $45 | Maintains | Outperform |
| 09/03/2019 | 38.57% | Canaccord Genuity | → $30 | Initiates Coverage On | → Buy |
| 09/03/2019 | 24.71% | Barclays | → $27 | Initiates Coverage On | → Overweight |
| 09/03/2019 | 24.71% | Baird | → $27 | Initiates Coverage On | → Outperform |
| 09/03/2019 | 29.33% | UBS | → $28 | Initiates Coverage On | → Buy |
What is the target price for InMode (INMD)?
The latest price target for InMode (NASDAQ: INMD) was reported by UBS on November 3, 2023. The analyst firm set a price target for $24.00 expecting INMD to rise to within 12 months (a possible 10.85% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for InMode (INMD)?
The latest analyst rating for InMode (NASDAQ: INMD) was provided by UBS, and InMode downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for InMode (INMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of InMode, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for InMode was filed on November 3, 2023 so you should expect the next rating to be made available sometime around November 3, 2024.
Is the Analyst Rating InMode (INMD) correct?
While ratings are subjective and will change, the latest InMode (INMD) rating was a downgraded with a price target of $52.00 to $24.00. The current price InMode (INMD) is trading at is $21.65, which is out of the analyst's predicted range.